References
- Lazenby A, Yardly JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic (‘‘microscopic’’) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989; 20: 18–28
- Giardiello FM, Lazenby AJ. The atypical colitides. Gastroenterol Clin North Am 1999; 28: 479–90
- Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis). Histopathologic fndings in 15 patients. Hum Pathol 987; 18: 839–48
- Chande N, Driman DK, Reynolds RPE. Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol 2005; 40: 343–7
- Fernandez-Banares F, Salas A, Forne M, Esteve M, Espinos J, Viver JM. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999; 92: 418–23
- Agnarsdottir M, Gunnlaugsson O, Orvar KB, Cariglia N, Birgisson S, Bjornsson S, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002; 47: 1122–228
- Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004; 53: 536–41
- Fernandez-Banares F, Salas A, Esteve M, Espinos J, Forne M, Viver JM. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003; 98: 340–7
- Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002; 97: 794–802
- Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis – proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005; 22: 277–84
- Ghilain JM, Schapira M, Maisin JM, De Maeght S, Piron A, Gerard R, et al. Colite lymphocytaire associée à la prise de lansoprazole [Lymphocytic colitis associated with lansoprazole treatment]. Gastroenterol Clin Biol 2000; 24: 960–2
- Wilcox GM, Mattia A. Collagenous colitis associated with lansoprazole. J Clin Gastroenterol 2002; 34: 164–6
- Thomson RD, Lestina LS, Bensen SP, Toor A, Maheshwari Y, Ratcliffe NR. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002; 97: 2908–13
- Mukherjee S. Diarrhea associated with lansoprazole. J Gastroenterol Hepatol 2003; 18: 602–3
- Rammer M, Kirchgatterer A, Hobling W, Knoflach P. Lansoprazole-associated collagenous colitis: a case report. Z Gastroenterol 2005; 43: 657–60
- Hilmer SN, Heap TR, Eckstein RP, Lauer CS, Shenfield GM. Microscopic colitis associated with exposure to lansoprazole. Med J Aust 2006; 184: 185–6
- Takahashi Y, Sakai H, Kuragari M, Suzuki T, Tauchi K, Minamimura T, et al. Expression of ATP1AL1, a non-gastric proton pump, in human colorectum. Jpn J Physiol 2002; 52: 317–21
- Binder HJ, Sangan P, Rajendran VM. Physiological and molecular studies of colonic H+, K + -ATPase. Semin Nephrol 1999; 19: 405–14
- Besancon M, Simon A, Sachs G, Shin JM. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem 1997; 272: 22438–46
- Martin, RM, Dunn, NR, Freemantle, S, Shakir, S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol, 50:366–372.
- Claessens AA, Heerdink ER, van Eijk JT, Lamers CB, Leufkens HG. Characteristics of diarrhea in 10,008 users of lansoprazole in daily practice: which co-factors contribute. Pharmacolepidemiol Drug Safety 2002; 11: 703–8
- Leufkens H, Claessens A, Heerdink E, vin Eijk J, Lamers CB. A prospective follow-up study of 5669 users of lansoprazole in daily practice. Aliment Pharmacol Ther 1997; 11: 887–97